A population-based, retrospective, cohort study of esophageal cancer missed at endoscopy

Background and study aims: Several studies have suggested that a significant minority of esophageal cancers are missed at endoscopy The aim of this study was to estimate the proportion of esophageal cancers missed at endoscopy on a national level, and to investigate the relationship between miss rates and patient and tumor characteristics.

Patients and methods: This retrospective, population-based, cohort study identified patients diagnosed with esophageal cancer between April 2011 and March 2012 in England, using two linked databases (National Oesophago-Gastric Cancer Audit and Hospital Episode Statistics). The main outcome was the rate of previous endoscopy within 3 – 36 months of cancer diagnosis. This was calculated for the overall cohort and by patient characteristics, including tumor site and disease stage.

Results: A total of 6943 new cases of esophageal cancer were identified, of which 7.8 % (95 % confidence interval 7.1 – 8.4) had undergone endoscopy in the 3 – 36 months preceding diagnosis. Of patients with stage 0/1 cancers, 34.0 % had undergone endoscopy in the 3 – 36 months before diagnosis compared with 10.0 % of stage 2 cancers and 4.5 % of stage 3/4 cancers. Of patients with stage 0/1 cancers, 22.1 % were diagnosed after ≥ 3 endoscopies in the previous 3 years. Patients diagnosed with an upper esophageal lesion were more likely to have had an endoscopy in the previous 3 – 12 months (P = 0.040). The most common diagnosis at previous endoscopy was an esophageal ulcer (48.2 % of investigations).

Conclusion: Esophageal cancer may be missed at endoscopy in up to 7.8 % of patients who are subsequently diagnosed with cancer. Endoscopists should make a detailed examination of the whole esophageal mucosa to avoid missing subtle early cancers and lesions in the proximal esophagus. Patients with an esophageal cancer may be misdiagnosed as having a benign esophageal ulcer.

• References

• 1 Cancer Research UK Statistical Information. Oesophageal Cancer Statistics. Available from: http://www.cancerresearchuk.org/cancer-info/cancerstats/types/oesophagus (Accessed: May 2013)
• 2 Groene O, Cromwell D, Hardwick RH et al. The National Oesophago-Gastric Cancer Audit. An audit of the care received by people with Oesophago-gastric Cancer in England and Wales. 2012 Annual Report. NHS Information Centre. Available from: https://catalogue.ic.nhs.uk/publications/clinical/oesophago-gastric/nati-clin-audi-supp-prog-oeso-gast-canc-2012/clin-audi-supp-prog-oeso-gast-2012-rep.pdf (Accessed: May 2013)
• 3 Richards M. The National Awareness and Early Diagnosis Initiative in England: assembling the evidence. Br J Cancer 2009; 101: 1-S4
• 4 Allum W, Blazeby J, Griffin S et al. Guidelines for the management of oesophageal and gastric cancer. Gut 2011; 60: 1449-1472
• 5 National Institute of Health and clinical excellence. Upper GI Endoscopy Service: Commissioning Guide. NICE Guidance. 2007. Available from: http://www.nice.org.uk/media/87f/b6/uppergiendoscopyserviceupdatecommissioningtool.pdf (Accessed: May 2013)
• 6 Raftopoulos S, Segarajasingam D, Burke V et al. A cohort study of missed and new cancers after esophagogastroduodenoscopy. Am J Gastroenterol 2010; 105: 1292-1297
• 7 Bloomfeld R, Bridgers D, Pineau B. Sensitivity of upper endoscopy in diagnosing esophageal cancer. Dysphagia 2005; 20: 278-282
• 8 Yalamarthi S, Witherspoon P, McCole D et al. Missed diagnoses in patients with upper gastrointestinal cancers. Endoscopy 2004; 36: 874-879
• 9 Cheung D, Evans T, Lawrence G et al. How often is upper gastrointestinal cancer missed during endoscopy?. Gut 2013; 62: A6
• 10 Cheung D, Menon S, Trudgill N. How commonly is oesophageal cancer missed at endoscopy (a UK primary care based study)?. Gut 2013; 62: A5-A6
• 11 Patel VM, Wyatt JI, Everett SM. Audit of upper GI cancer diagnosis by endoscopy: are diagnoses being missed?. Gut 2012; 61: A388
• 12 Parsons S. Are we missing gastro-oesophageal cancer at endoscopy?. Ann R Coll Surg Engl 2010; DOI: 10.1308/147870810X12888732147 634.
• 13 Guanrei Y, Songliang Q, He H et al. Natural history of early esophageal squamous carcinoma and early adenocarcinoma of the gastric cardia in the People’s Republic of China. Endoscopy 1988; 20: 95-98
• 14 Wang GQ, Wei WQ, Hao CQ et al. [Natural progression of early esophageal squamous cell carcinoma]. Article in Chinese. Zhonghua Zhong Liu Za Zhi 2010; 32: 600-602
• 15 Chadwick G, Groene O, Cromwell D et al. The National Oesophago-Gastric Cancer Audit. An audit of the care received by people with Oesophago-gastric Cancer in England and Wales. 2013 Annual Report. NHS Information Centre. Available from: https://catalogue.ic.nhs.uk/publications/clinical/oesophago-gastric/nati-clin-audi-supp-prog-oeso-gast-canc-2013/clin-audi-supp-prog-oeso-gast-2013-rep.pdf (Accessed: May 2013)
• 16 Health and Social Care Information Centre. Hospital Episode Statistics. NHS Information Centre. 2012 Available from: http://www.hscic.gov.uk/hes (Accessed: May 2013)
• 17 World Health Organization. International classification of diseases and related health problems. 10th Edition. 2010 Available from: http://apps.who.int/classifications/icd10/browse/2010/en (Accessed: May 2013)
• 18 Office of Population Censuses and Surveys Classification of Interventions and Procedures: Volume II, Version 4.6. NHS Classification Service London: The Stationary Office; 2011
• 19 Palser T, Cromwell D. National Oesophago-Gastric Cancer Audit: Data Manual. 2007 Available from: http://www.hscic.gov.uk/article/2021/Website-Search?q=nogca&area=both (Accessed: May 2013)
• 20 eds. Union for International Cancer Control. TNM Classification of malignant tumours. 6th edn. Sobin LH, Wittekind CH. Hoboken, New Jersey: John Wiley & Sons; 2002
• 21 Royston P. Multiple imputation using chained equations: update of ICE. Stata J 2005; 5: 527-536
• 22 de Jonge PJ, van Blankenstein M, Looman CW et al. Risk of malignant progression in patients with Barrett’s oesophagus: a Dutch nationwide cohort study. Gut 2010; 59: 1030-1036
• 23 Everett SM, Axon AT. Early gastric cancer in Europe. Gut 1997; 41: 142-150
• 24 Chung CS, Wang HP. Screening for precancerous lesions of upper gastrointestinal tract: from the endoscopists’ viewpoint. Gastroenterol Res Pract 2013; 2013: 681439
• 25 Bramble MG, Suvakovic Z, Hungin AP. Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy. Gut 2000; 46: 464-467
• 26 Meineche-Schmidt V, Jorgensen T. ‘Alarm symptoms’ in patients with dyspepsia: a three-year prospective study from general practice. Scand J Gastroenterol 2002; 37: 999-1007
• 27 Higuchi D, Sugawa C, Shah SH et al. Etiology, treatment, and outcome of esophageal ulcers: a 10-year experience in an urban emergency hospital. J Gastrointest Surg 2003; 7: 836-842
• 28 Bennett C, Vakil N, Bergman J et al. Consensus statements for management of Barrett’s dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology 2012; 143: 336-346
• 29 Petticrew MP, Sowden AJ, Lister-Sharp D et al. False-negative results in screening programmes: systematic review of impact and implications. Health Technol Assess 2000; 4: 1-120
• 30 Burns EM, Rigby E, Mamidanna R et al. Systematic review of discharge coding accuracy. J Public Health (Oxf) 2012; 34: 138-148